1-4 of 4
Noemie De Gunzburg
Close
Sort by
Journal Articles

Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study

CME Clinical Trials & Observations
Corentin Orvain, Marie Balsat, Emmanuelle Tavernier, Jean-Pierre Marolleau, Thomas Pabst, Patrice Chevallier, Noémie de Gunzburg, Victoria Cacheux, Françoise Huguet, Sylvain Chantepie, Denis Caillot, Yves Chalandon, Jamilé Frayfer, Caroline Bonmati, Véronique Lheritier, Norbert Ifrah, Hervé Dombret, Nicolas Boissel, Mathilde Hunault-Berger
Journal: Blood
Blood (2020) 136 (3): 328–338.
https://doi.org/10.1182/blood.2020004919
Published: 2020
Includes: Supplemental data
Journal Articles

Prevention of Venous Thrombotic Events in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatric-Inspired Protocol - a Graall Study

Corentin Orvain, Marie Balsat, MD, Véronique Lhéritier, Emmanuelle Tavernier, Jean-Pierre Marolleau, MD PhD, Thomas Pabst, MD PhD, Patrice Chevallier, MD PhD, Noémie De Gunzburg, MD, Victoria Cacheux, Francoise Huguet, MD, Sylvain Chantepie, MD, Denis Caillot, Yves Chalandon, MD, Jamilé Frayfer, MD, Caroline Bonmati, MD, Nicolas Boissel, MD PhD, Hervé Dombret, MD PhD, Norbert Ifrah, Mathilde Hunault-Berger, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2776.
https://doi.org/10.1182/blood.V128.22.2776.2776
Published: 2016
Journal Articles

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Amélie Trinquand, MD, Aline Tanguy-Schmidt, MD, Raouf Ben Abdelali, MD, Jérôme Lambert, Etienne Lengliné, MD, Noemie De Gunzburg, Dominique Payet-Bornet, PhD, Ludovic Lhermitte, MD, Hossein Mossafa, PhD, Véronique Lhéritier, Françoise Huguet, Agnès Buzyn, MD, PhD, Thibaut Leguay, MD, Jean-Yves Cahn, MD, Xavier Thomas, MD, Yves Chalandon, Andre Delannoy, MD, Caroline Bonmati, MD, Sebastien Maury, MD, Bertrand Nadel, PhD, Elizabeth Macintyre, MD, PhD, Norbert Ifrah, MD, Herve Dombret, MD, Vahid Asnafi, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 881.
https://doi.org/10.1182/blood.V120.21.881.881
Published: 2012
Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, MD, PhD, Dominique Bordessoule, Jean-Noel Bastie, MD, PhD, Ollivier Legrand, Xavier Thomas, MD, PhD, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, MD, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, MD, PhD, Estelle Henry, Philippe Rousselot, MD, PhD, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 6.
https://doi.org/10.1182/blood.V118.21.6.6
Published: 2011